DxS appoints Jeff Devlin as new Chief Operating Officer
DxS Ltd has announced the appointment of Jeff Devlin as Chief Operating Officer.
Prior to DxS, Jeff held positions as Executive VP and Executive Committee member of Shire Pharmaceuticals, where he played a key role in strategy and integration. Before this he was a Partner in Ernst and Young’s life science division. Jeff has a BSc in Physics from the University of Edinburgh and an MSc in Marketing from the University of Strathclyde.
The appointment is one of a number planned for 2009, continuing DxS’ expansion which has seen the company’s workforce more than double in size in the last twelve months with new manufacturing space taken at their Manchester site and a global distribution deal agreed with Roche Molecular Diagnostics.
Most read news
Other news from the department people
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Merck and Pfizer Collaborate with Dako - Development of Companion Diagnostic for Investigational anti-PD-L1 Antibody, Avelumab
SALVE Project Enters Second Phase - Successful evaluation phase prompts University of Ulm and Carl Zeiss to continue with their joint venture to develop a high-performance transmission electron microscope
Semiconductors for Cool Computers
Licence to go where no chemist has gone before